Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berthold Lausecker

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Pharmacokinetics|March 16, 2013
A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humansDietmar Schwab, Agnes Portron, Zoe Backholer, et al.
Bioanalysis|November 19, 2010
Towards harmonized regulations for bioanalysis: moving forward!Peter van Amsterdam, Berthold Lausecker, Silke Luedtke, et al.
Bioanalysis|November 19, 2010
European Bioanalysis Forum and the way forward towards harmonized regulationsBerthold Lausecker, Peter van Amsterdam, Margarete Brudny-Kloeppel, et al.
Bioanalysis|March 29, 2012
'Large Meets Small': connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS)Philip Timmerman, Berthold Lausecker, Begona Barosso, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 28, 2010
Workshop/conference report on EMA draft guideline on validation of bioanalytical methodsHenning Blume, Erich Brendel, Margarete Brudny-Klöppel, et al.
Journal of Clinical Pharmacology|August 14, 2013
Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activityFelicitas Stoll, Jürgen Burhenne, Berthold Lausecker, et al.
Bioanalysis|July 16, 2016
Co-medication and interference testing in bioanalysis: a European Bioanalysis Forum recommendationMarcel de Zwart, Berthold Lausecker, Susanne Globig, et al.
Bioanalysis|November 22, 2014
European Bioanalysis Forum: recommendation for dealing with internal standard variabilityStephen White, Neil Adcock, Walid Elbast, et al.
Bioanalysis|April 23, 2011
From challenges to solutions. European Bioanalysis Forum 3rd Annual Open Symposium, Hesperia Towers, Barcelona, Spain, 1-3 December 2010Richard W Abbott, Ben Gordon, Peter van Amsterdam, et al.
Bioanalysis|November 19, 2010
Incurred sample reproducibility: views and recommendations by the European Bioanalysis ForumPhilip Timmerman, Silke Luedtke, Peter van Amsterdam, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Pharmacokinetics|March 16, 2013
A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humansDietmar Schwab, Agnes Portron, Zoe Backholer, et al.
Bioanalysis|November 19, 2010
Towards harmonized regulations for bioanalysis: moving forward!Peter van Amsterdam, Berthold Lausecker, Silke Luedtke, et al.
Bioanalysis|November 19, 2010
European Bioanalysis Forum and the way forward towards harmonized regulationsBerthold Lausecker, Peter van Amsterdam, Margarete Brudny-Kloeppel, et al.
Bioanalysis|March 29, 2012
'Large Meets Small': connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS)Philip Timmerman, Berthold Lausecker, Begona Barosso, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 28, 2010
Workshop/conference report on EMA draft guideline on validation of bioanalytical methodsHenning Blume, Erich Brendel, Margarete Brudny-Klöppel, et al.
Journal of Clinical Pharmacology|August 14, 2013
Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activityFelicitas Stoll, Jürgen Burhenne, Berthold Lausecker, et al.
Bioanalysis|July 16, 2016
Co-medication and interference testing in bioanalysis: a European Bioanalysis Forum recommendationMarcel de Zwart, Berthold Lausecker, Susanne Globig, et al.
Bioanalysis|November 22, 2014
European Bioanalysis Forum: recommendation for dealing with internal standard variabilityStephen White, Neil Adcock, Walid Elbast, et al.
Bioanalysis|April 23, 2011
From challenges to solutions. European Bioanalysis Forum 3rd Annual Open Symposium, Hesperia Towers, Barcelona, Spain, 1-3 December 2010Richard W Abbott, Ben Gordon, Peter van Amsterdam, et al.
Bioanalysis|November 19, 2010
Incurred sample reproducibility: views and recommendations by the European Bioanalysis ForumPhilip Timmerman, Silke Luedtke, Peter van Amsterdam, et al.
Pageof 2